Antiviral Chemotherapy 5: New Directions For Clinical Applications And Research-..

Código: 1018791 Marca:
R$ 1.410,92
até 4x de R$ 352,73 sem juros
ou R$ 1.340,37 via Pix
Comprar Estoque: 45 dias úteis
    • 1x de R$ 1.410,92 sem juros
    • 2x de R$ 705,46 sem juros
    • 3x de R$ 470,30 sem juros
    • 4x de R$ 352,73 sem juros
  • R$ 1.340,37 Pix
  • R$ 1.410,92 Boleto Bancário
* Este prazo de entrega está considerando a disponibilidade do produto + prazo de entrega.
Scientists and clinicians attending the last "New Directions in Antiviral Therapy" conference in late 1994 could hardly have predicted the revolution in the management of patients with HIV infection that has occurred since. Two new classes of antiretrovirals have been licensed, the second-site RT inhibitors and the protease inhibitors; the long in- cubation period of active HIV infection, when the infection is clinically latent, is now un- derstood to be a period of intense viral replication and turnover of CD4 lymphocytes; measurements of HI V RNA concentration in plasma have been shown to be essential tools for monitoring the course of HIV infection, deciding when to treat, and assessing the re- sults of treatment; and finally, combinations of antiretrovirals, particularly combinations including protease inhibitors, have been shown to have dramatically beneficial effects on patients with HIV infection. These advances, coupled with new drugs for the management of herpesvirus infections, have made dramatic differences in the quality and length of life of HIV-infected patients. Additional advances have been made since 1994 in the prevention or management of influenza virus (zanamavir), respiratory syncytial virus (palvizumab), hepatitis B virus (lamivudine and famciclovir), and enterovirus infections (pleconaril). It is difficult to re- member that only slightly more than a decade ago there were only a handful of antiviral agents available (none of which were antiretrovirals), and a number of those were either highly toxic, of dubious efficacy, or both.
ISBN 9780306461071
Autor(a) Mills, John
Editora Springer Publishing
Ano de edição 1999
Páginas 271
Acabamento Capa Dura

Produtos relacionados

R$ 1.410,92
até 4x de R$ 352,73 sem juros
ou R$ 1.340,37 via Pix
Comprar Estoque: 45 dias úteis
Sobre a loja

Myre Livraria, sua livraria online especializada em importação e revenda de livros nacionais e internacionais. Oferecemos uma vasta seleção de materiais didáticos de alta qualidade para aprender inglês, espanhol, francês, alemão e muito mais. Aproveite preços competitivos e entrega rápida em todo o Brasil

Social
Pague com
  • proxy-pagali-v2
  • Pix
Selos
  • Site Seguro

Myre Editora Ltda. - CNPJ: 50.295.718/0001-20 © Todos os direitos reservados. 2026


Para continuar, informe seu e-mail

Utilizamos cookies para que você tenha a melhor experiência em nosso site. Para saber mais acesse nossa página de Política de Privacidade